Your browser doesn't support javascript.
loading
An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective.
Salzberger, Bernd; Mellmann, Alexander; Bludau, Anna; Ciesek, Sandra; Corman, Victor; Dilthey, Alexander; Donker, Tjibbe; Eckmanns, Tim; Egelkamp, Richard; Gatermann, Sören G; Grundmann, Hajo; Häcker, Georg; Kaase, Martin; Lange, Berit; Mielke, Martin; Pletz, Mathias W; Semmler, Torsten; Thürmer, Andrea; Wieler, Lothar H; Wolff, Thorsten; Widmer, Andreas F; Scheithauer, Simone.
Affiliation
  • Salzberger B; Department for Infection Control and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. bernd.salzberger@ukr.de.
  • Mellmann A; Institute for Hygiene, University Hospital Münster, Robert-Koch-Straße 41, 48149, Münster, Germany. mellmann@uni-muenster.de.
  • Bludau A; Department for Infection Control and Infectious Diseases, University Medical Center (UMG), Georg-August University Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Germany.
  • Ciesek S; Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt Am Main, Germany.
  • Corman V; Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Dilthey A; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Donker T; Institute for Infection Prevention and Hospital Epidemiology, University Medical Center Freiburg, Freiburg, Germany.
  • Eckmanns T; Robert Koch Institute, Berlin, Germany.
  • Egelkamp R; Next Generation Sequencing, Public Health Agency of Lower Saxony, Hanover, Germany.
  • Gatermann SG; Department of Medical Microbiology, Ruhr University Bochum, Bochum, Germany.
  • Grundmann H; Institute for Infection Prevention and Hospital Epidemiology, University Medical Center Freiburg, Freiburg, Germany.
  • Häcker G; Faculty of Medicine, Institute of Medical Microbiology and Hygiene, Medical Centre University of Freiburg, Freiburg, Germany.
  • Kaase M; Department for Infection Control and Infectious Diseases, University Medical Center (UMG), Georg-August University Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Germany.
  • Lange B; Department of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.
  • Mielke M; Robert Koch Institute, Berlin, Germany.
  • Pletz MW; Institute of Infectious Diseases and Infection Control, University Hospital, Jena, Germany.
  • Semmler T; Robert Koch Institute, Berlin, Germany.
  • Thürmer A; Robert Koch Institute, Berlin, Germany.
  • Wieler LH; Robert Koch Institute, Berlin, Germany.
  • Wolff T; Robert Koch Institute, Berlin, Germany.
  • Widmer AF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Scheithauer S; Department for Infection Control and Infectious Diseases, University Medical Center (UMG), Georg-August University Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Germany. simone.scheithauer@med.uni-goettingen.de.
Infection ; 51(4): 805-811, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37129842
ABSTRACT
The SARS-CoV-2 pandemic has highlighted the importance of viable infection surveillance and the relevant infrastructure. From a German perspective, an integral part of this infrastructure, genomic pathogen sequencing, was at best fragmentary and stretched to its limits due to the lack or inefficient use of equipment, human resources, data management and coordination. The experience in other countries has shown that the rate of sequenced positive samples and linkage of genomic and epidemiological data (person, place, time) represent important factors for a successful application of genomic pathogen surveillance. Planning, establishing and consistently supporting adequate structures for genomic pathogen surveillance will be crucial to identify and combat future pandemics as well as other challenges in infectious diseases such as multi-drug resistant bacteria and healthcare-associated infections. Therefore, the authors propose a multifaceted and coordinated process for the definition of procedural, legal and technical standards for comprehensive genomic pathogen surveillance in Germany, covering the areas of genomic sequencing, data collection and data linkage, as well as target pathogens. A comparative analysis of the structures established in Germany and in other countries is applied. This proposal aims to better tackle epi- and pandemics to come and take action from the "lessons learned" from the SARS-CoV-2 pandemic.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cross Infection / COVID-19 Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Infection Year: 2023 Document type: Article Affiliation country: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cross Infection / COVID-19 Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Infection Year: 2023 Document type: Article Affiliation country: Alemania
...